Boji Medical Technology Co.,Ltd. (SHE:300404)
China
· Delayed Price · Currency is CNY 10.14
-0.01 (-0.10%)
Mar 9, 2026, 4:00 PM EDT
Boji Medical Technology Revenue
Boji Medical Technology had revenue of 222.87M CNY in the quarter ending September 30, 2025, with 3.78% growth. This brings the company's revenue in the last twelve months to 770.19M, up 2.26% year-over-year. In the year 2024, Boji Medical Technology had annual revenue of 742.02M with 33.50% growth.
Revenue (ttm)
770.19M
Revenue Growth
+2.26%
P/S Ratio
5.04
Revenue / Employee
639.16K
Employees
1,205
Market Cap
3.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 742.02M | 186.19M | 33.50% |
| Dec 31, 2023 | 555.83M | 132.15M | 31.19% |
| Jan 1, 2023 | 423.68M | 99.48M | 30.68% |
| Jan 1, 2022 | 324.20M | 63.73M | 24.47% |
| Dec 31, 2020 | 260.47M | 36.40M | 16.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao Vland Biotech INC. | 1.39B |
| Shenzhen Bioeasy Biotechnology | 251.83M |
| Shanghai Shen Lian Biomedical | 288.27M |
| Baolingbao Biology | 2.69B |
| Zhejiang Wecome Pharmaceutical Company | 131.67M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Guanhao Biotech | 392.83M |
| Hinova Pharmaceuticals | 20.67M |